As the largest cancer and blood disease program in North Texas, and one of the largest in the U.S., UT Southwestern physicians provide world-class care to more than 350 children with newly-diagnosed cancer and more than 600 children with newly-diagnosed blood disease each year at Children’s Health℠.
The Pauline Allen Gill Center for Cancer and Blood Disorders is a pediatric cancer program for the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in North Texas. As such we offer patients the ability to participate in the broadest possible range of clinical trials, giving them access to novel therapies not available at other facilities as we continue to advance the discovery of new treatments.
The Pauline Allen Gill Center for Cancer and Blood Disorders is the pediatric hematology center housing where UT Southwestern physicians have developed innovative clinical care and research programs such as the Young Women’s Blood Disorder program and the North Texas Sickle Cell Disease Clinical Trial Unit.
Further information on available novel therapies is readily available during clinic visits and through virtual tools such as the Simmons Cancer Center email, and Children’s Health clinical research trials list.
Our Clinical Trials Groups
Childrens Oncology Group (COG)
Pediatric Early Phase Clinical Trials Network (PEP-CTN), non-core members
The Neurofibromatosis (NF) Clinical Trials Consortium
Therapeutic Advances in Childhood Leukemia & Lymphoma Consortium (TACL)
Sunshine Consortium
ACCESS/REDIAL, Case Ascertainment for Epidemiologic Studies of Childhood Cancers and Hematological Conditions Used by Adolescent and Childhood Cancer Epidemiology and Susceptibility Service (ACCESS) for Texas and Reducing Ethnic Disparities in Acute Leukemias (REDIAL) Consortium
Gain (Genomic Assessment Informs Novel Therapy) Consortium
